Related Experiment Video
Updated: Oct 13, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Radical surgery for rectal cancer: why we fail and rationale for current clinical trials of adjuvant therapy
1Lucille Markey Cancer Center, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536-0098, USA.
Abstract:
The major goals in the treatment of patients with rectal cancer are overall cure, maximizing local control, and maintaining quality of life. Quality of life issues include avoidance of a permanent stoma and maintaining adequate bowel, sexual, and urinary function. Optimizing the surgical technique with a more selective application of adjuvant therapy will meet these goals. This article describes the likely explanations for local and distant recurrence and delineates current clinical trials of adjuvant therapy directed toward minimizing failure despite potentially curative surgical resection.